Impact Factor
3.48
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.30
555 total citations
h5-index
30
h5 depth signal
Cited share
73.2%
131 of 179
Total citations
555
Citation footprint
Metric signal
3.11
External metric anchor
Self-citation
0.9%
5 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
312
China
175
Italy
142
Japan
131
United Kingdom
96
Citing Fields of Research
Pharmacology & Toxicology
147
Cardiology
136
Diabetes
100
Anesthetic & Pain Medicine
90
Psychiatry
78
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
4,116
Articles tracked across the journal lifetime
Indexed publication set
179
131 cited publications
Last 12 months
112
9.3 publications/month
Open access share
50.9%
57 OA publications in the last year
Leading citing country
United States
312 citing publications
Leading citing field
Pharmacology & Toxicology
147 citing publications
Latest tracked publication
15 October 2026
10 recent records available
Coverage & Indexing History
v26n1, 2006-
v26n1, 2006-
Research Focus & Classification
Indexed Subjects
Pharmacology & Toxicology
Cardiology
Dermatology
Medical Ethics
Psychiatry
Diabetes
Musculoskeletal Disorders
Broad Categories
Drug Therapy
Pharmacology
Musculoskeletal Disorders
Medical Ethics
Diabetes
Allergies
Hematology
Auto-Inflammatory Disorders
Lung Cancer
MeSH Descriptors
Clinical Trials as Topic
Drug Evaluation
Drug Therapy
Drugs, Investigational
Investigational New Drug Application
Pharmaceutical Preparations
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
03
04
DOI 10.1007/s40261-026-01599-z
Open DOI
Serotonergic Toxicity and Hyponatremia Associated with Antidepressant Therapy: The Pivotal Role of SIADH
05
06
DOI 10.1007/s40261-026-01591-7
Open DOI
Healthcare Cost Patterns in CDK4/6 Inhibitor-Treated HR+/HER2- Metastatic Breast Cancer
07
DOI 10.1007/s40261-026-01597-1
Open DOI
Symptomatic Interventions for Allergic Rhinitis Without Comorbid Asthma: A Dose-Stratified Network Meta-analysis
Background Allergic rhinitis (AR) is a prevalent chronic condition with a substantial global burden. Although numerous therapeutic interventions exist, their comparative efficacy and safety remain unclear. The objective was to evaluate s...
08
DOI 10.1007/s40261-026-01592-6
Open DOI
Real-World Treatment Patterns, Healthcare Resource Use, and Costs in Patients with Follicular Lymphoma, Waldenström Macroglobulinemia, and Marginal Zone Lymphoma: A Claims-Based Study in the USA
Background and Objectives Indolent non-Hodgkin’s lymphomas (NHL) are associated with relapses necessitating recurrent treatment and lifelong care. However, contemporary real-world evidence of the disease burden among patients with indole...
09
10
Bibliographical & Catalog Notes
Title from cover.
Also issued online.